These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 3901038
1. Modulation of gene expression during terminal cell differentiation. Marks PA, Sheffery M, Rifkind RA. Prog Clin Biol Res; 1985; 191():185-203. PubMed ID: 3901038 [Abstract] [Full Text] [Related]
2. Modulation of gene expression during terminal cell differentiation: murine erythroleukemia. Marks PA, Murate T, Kaneda T, Ravetch J, Rifkind RA. Symp Fundam Cancer Res; 1984; 37():327-40. PubMed ID: 6084863 [Abstract] [Full Text] [Related]
3. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC. Marks PA, Michaeli J, Jackson J, Richon VM, Rifkind RA. Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574 [Abstract] [Full Text] [Related]
4. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation. Marks PA, Ramsay R, Sheffery M, Rifkind RA. Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077 [Abstract] [Full Text] [Related]
5. Regulation of globin gene expression during induced erythroid cell differentiation. Rifkind RA, Sheffery M, Profous-Juchelka HR, Reuben RC, Marks PA. Prog Clin Biol Res; 1983; 134():183-92. PubMed ID: 6582518 [Abstract] [Full Text] [Related]
10. Induced erythroleukemia differentiation: cellular and molecular aspects. Rifkind RA, Sheffery M, Marks PA. Blood Cells; 1987; 13(1-2):277-84. PubMed ID: 3311222 [Abstract] [Full Text] [Related]
11. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells. Richon VM, Rifkind RA, Marks PA. Cell Growth Differ; 1992 Jul; 3(7):413-20. PubMed ID: 1419904 [Abstract] [Full Text] [Related]
12. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application. Marks PA, Rifkind RA. Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266 [Abstract] [Full Text] [Related]
13. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression. Suhasini M, Boss GR, Pascual FE, Pilz RB. Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161 [Abstract] [Full Text] [Related]
14. Changes in p34cdc2 kinase activity and cyclin A during induced differentiation of murine erythroleukemia cells. Kiyokawa H, Ngo L, Kurosaki T, Rifkind RA, Marks PA. Cell Growth Differ; 1992 Jun; 3(6):377-83. PubMed ID: 1419901 [Abstract] [Full Text] [Related]
15. Inducer-mediated commitment of murine erythroleukemia cells to terminal cell division: the expression of commitment. Murate T, Kaneda T, Rifkind RA, Marks PA. Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3394-8. PubMed ID: 6203120 [Abstract] [Full Text] [Related]
18. Induction of transformed cells to terminal differentiation. Marks PA, Sheffery M, Ramsay R, Ikeda K, Rifkind RA. Ann N Y Acad Sci; 1987 Jun; 511():246-55. PubMed ID: 3326466 [Abstract] [Full Text] [Related]